Results 11 to 20 of about 7,007,196 (291)
Interim opioid agonist treatment for opioid addiction: a systematic review [PDF]
Harm Reduction Journal, 2022 Background Opioid use disorder is a public health problem and treatment variability, coverage and accessibility poses some challenges. The study’s objective is to review the impact of interim opioid agonist treatment (OAT), a short-term approach for ...
Laura Samsó Jofra +3 more
doaj +6 more sources
Journal of Substance Abuse Treatment, 2020 Patients recovering from opioid use disorders (OUD) may be prone to relapse and opioid misuse in the postoperative period due to re-exposure to prescription opioids for pain control. This retrospective study analyzed the incidence of confirmed opioid misuse in the postoperative period in patients with OUDs enrolled in an opioid agonist treatment (OAT ...
Khodadad Namiranian
exaly +4 more sources
Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
JAMA, 2017 Are different opioid agonist treatments (eg, methadone vs buprenorphine) associated with differences in efficacy for treating prescription opioid dependence, and is long-term maintenance of opioid agonist treatment associated with differences in efficacy compared with opioid taper or psychological treatments alone?For patients who are dependent on ...
Nielsen, S, Larance, B, Lintzeris, N
core +6 more sources
Alcohol use in opioid agonist treatment [PDF]
Addiction Science & Clinical Practice, 2016 Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best ...
Nolan, Seonaid, Klimas, Jan, Wood, Evan
openaire +6 more sources
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Addiction Science & Clinical Practice, 2022 Background Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment ...
Nathaniel Day, Maureen Wass, Kelly Smith
doaj +3 more sources
Exploring the role of mu opioid receptor (OPRM1) and CYP2B6 gene variations for methadone pharmacogenomics. Can these variations be used to advance toxicological interpretation post-mortem?. [PDF]
Methadone is increasingly involved in drug overdose cases and the molecular actions of the drug in vivo are largely unknown requiring elucidation. This study set out to examine the relationship between methadone toxicity and CYP2B6 and mu (μ) opioid ...
Bunten, Hannah
core +9 more sources
European Psychiatry, 2023 Introduction Studies consistently show that patients with prescription opioid use disorder (OUD) respond to buprenorphine treatment. Few studies have followed these patients in the long-term.
R. Weiss, M. L. Griffin
doaj +1 more source
Opioid Substitution: More than Only Methadone!
European Psychiatry, 2022 Opioid misuse and its rising rates of morbidity and associated mortality is an increasing area of concern worldwide. The licit/illicit consumption of opioids ranging from plant-based substances and pharmaceutical drugs (particularly analgesia) to the new
M. Torrens
doaj +1 more source
Substance Abuse Treatment, Prevention, and Policy, 2022 Background Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of ...
Heather Palis +6 more
doaj +1 more source
BMJ Open, 2021 Objective To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.Design We used quarterly, cross-sectional data on the number and proportion of people prescribed opioid agonist treatment ...
Fiona Kouyoumdjian +4 more
doaj +1 more source